BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test

[at noodls] – WALTHAM, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the … more

View todays social media effects on BGMD

View the latest stocks trending across Twitter. Click to view dashboard

See who BG is hiring next, click here to view